These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33119213)

  • 1. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
    Ramani NS; Patel KP; Routbort MJ; Alvarez H; Broaddus R; Chen H; Rashid A; Lazar A; Lucas FAS; Yao H; Manekia J; Dang H; Barkoh BA; Medeiros LJ; Luthra R; Roy-Chowdhuri S
    Arch Pathol Lab Med; 2021 Nov; 145(11):1405-1412. PubMed ID: 33493304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions.
    Han LM; Khanafshar E; Afshar AR; Calkins SM
    Cancer Cytopathol; 2020 Jul; 128(7):499-505. PubMed ID: 32196967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the success of next-generation sequencing in cytology specimens.
    Roy-Chowdhuri S; Goswami RS; Chen H; Patel KP; Routbort MJ; Singh RR; Broaddus RR; Barkoh BA; Manekia J; Yao H; Medeiros LJ; Staerkel G; Luthra R; Stewart J
    Cancer Cytopathol; 2015 Nov; 123(11):659-68. PubMed ID: 26230354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma.
    Baum JE; Zhang P; Hoda RS; Geraghty B; Rennert H; Narula N; Fernandes HD
    Cancer Cytopathol; 2017 Jun; 125(6):398-406. PubMed ID: 28272845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
    Seto K; Masago K; Fujita S; Haneda M; Horio Y; Hida T; Kuroda H; Hosoda W; Okubo KI
    Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing of cytologic preparations: An analysis of quality metrics.
    Hwang DH; Garcia EP; Ducar MD; Cibas ES; Sholl LM
    Cancer Cytopathol; 2017 Oct; 125(10):786-794. PubMed ID: 28727266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing in cytology.
    Pisapia P; Pepe F; Sgariglia R; Nacchio M; Russo G; Conticelli F; Girolami I; Eccher A; Bellevicine C; Vigliar E; Malapelle U; Troncone G
    Cytopathology; 2021 Sep; 32(5):588-595. PubMed ID: 33792981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing.
    Nikiforova MN; Lepe M; Tolino LA; Miller ME; Ohori NP; Wald AI; Landau MS; Kaya C; Malapelle U; Bellevicine C; Troncone G; Nikiforov YE; Baloch Z
    Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
    Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
    Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience.
    Roy-Chowdhuri S; Stewart J
    Arch Pathol Lab Med; 2016 Nov; 140(11):1191-1199. PubMed ID: 27333361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.
    Al Zoughbi W; Kim D; Alperstein SA; Ohara K; Manohar J; Greco N; Khani F; Robinson BD; Rao RA; Elemento O; Mosquera JM; Siddiqui MT
    Cancer Cytopathol; 2021 Nov; 129(11):874-883. PubMed ID: 33929788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
    Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cytology centrifuged supernatants improves cost and turnaround time for targeted next generation sequencing.
    Gokozan H; Harbhajanka A; Bomeisl P; Michael CW; Sadri N
    Diagn Cytopathol; 2020 Dec; 48(12):1167-1172. PubMed ID: 32697040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
    Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
    Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.
    Goswami RS; Luthra R; Singh RR; Patel KP; Routbort MJ; Aldape KD; Yao H; Dang HD; Barkoh BA; Manekia J; Medeiros LJ; Roy-Chowdhuri S; Stewart J; Broaddus RR; Chen H
    Am J Clin Pathol; 2016 Feb; 145(2):222-37. PubMed ID: 27124905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: Cellularity and storage time.
    Heymann JJ; Yoxtheimer LM; Park HJ; Fernandez EM; Facey KE; Alperstein SA; Tran HV; Baek I; Scognamiglio T; Rennert H; Siddiqui MT; Song W
    Cancer Cytopathol; 2020 Sep; 128(9):656-672. PubMed ID: 32267620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.